Bayer AG NA • BAYN
Capital at risk.
Calendar
About Bayer AG NA
Ticker
BAYN
Trading on
XETRA
ISIN
DE000BAY0017
Industry
Drug Manufacturers - General
Sector
Healthcare
CEO
William N. Anderson
Headquarters
Kaiser-Wilhelm-Allee 1, Leverkusen, undefined, Germany, 51368
Employees
89,556
Website
bayer.com
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Metrics
BasicAdvanced
Market cap
€27B
P/E ratio
-
EPS
-€3.48
Dividend Yield
0.40%
Beta
1
Forward P/E ratio
5.52
EBIDTA
€5.05B
Ex dividend date
2025-04-28
Price & volume
Market cap
€27B
Average daily volume
2.1M
90-day return
-
30-day return
-
7-day return
-
Dividends
Dividend per share
€0.11
Dividend yield
0.40%
Forward dividend per share
€0.11
Forward dividend yield
0.40%
Payout ratio
2.20%
Valuation
P/E ratio
0
Forward P/E
5.52
PEG ratio
4.72
Trailing P/E
0
Price to sales
0.58
Price to book
0.93
Earnings
EPS
-€3.48
EPS estimate (current quarter)
€0.79
EPS estimate (next quarter)
€0.18
EBITDA
€5.05B
Revenues (TTM)
€46.2B
Revenues per share (TTM)
€47.00
Technicals
Beta
1
52-week High
€29.93
52-week Low
€18.29
50-day moving average
€27.87
200-day moving average
€25.10
Short ratio
0
Short %
0.00%
Management effectiveness
ROE (TTM)
-10.27%
ROA (TTM)
1.53%
Profit margin
-7.40%
Gross profit margin
€25.4B
Operating margin
9.26%
Growth
Quarterly earnings growth (YoY)
-35.20%
Quarterly revenue growth (YoY)
-3.60%
Share stats
Outstanding Shares
982M
Float
982M
Insiders %
-
Institutions %
49.48%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
windowbar_chart_4_bars
QuarterlyAnnual
QuarterlyAnnual